![Mesoblast’s Stem Cell Therapy Shows 83% Survival in Ventilator-Dependent COVID-19 Patients]()
by admin | Apr 25, 2020 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News
April 24, 2020 – By Mark Terry – Melbourne, Australia and New York-based Mesoblast Limited announced that in a study of COVID-19 patients with moderate to severe acute respiratory distress syndrome (ARDS), there was 83% survival with two intravenous...
![Mesoblast’s Stem Cell Therapy Shows 83% Survival in Ventilator-Dependent COVID-19 Patients]()
by admin | Apr 24, 2020 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News
April 24, 2020 / Yimy Villa Dr. John Zaia, City of hope The governing Board of the California Institute for Regenerative Medicine (CIRM) continued its commitment to help with the coronavirus pandemic by awarding $749,999 to Dr. John Zaia at City of Hope. He will be...
![Mesoblast’s Stem Cell Therapy Shows 83% Survival in Ventilator-Dependent COVID-19 Patients]()
by admin | Apr 15, 2020 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
Personalized Stem Cells, Inc. and Calidi Biotherapeutics collaborate to rapidly bring a stem cell therapy into clinical trials for COVID-19 patients. POWAY, CALIFORNIA, USA, April 13, 2020 /EINPresswire.com/ — The scientific community is racing to bring new...
![Mesoblast’s Stem Cell Therapy Shows 83% Survival in Ventilator-Dependent COVID-19 Patients]()
by admin | Apr 9, 2020 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
Dear Friends, We hope that in the midst of these unprecedented times that this message finds you and your loved ones healthy and well. At present – and without hyperbole – our world is faced with crisis that knows no borders, race, or creed. While an...
![Mesoblast’s Stem Cell Therapy Shows 83% Survival in Ventilator-Dependent COVID-19 Patients]()
by admin | Apr 9, 2020 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News
FOR IMMEDIATE RELEASE: APRIL 9, 2020 After a lightning round of proposals and reviews, an international team of scientists led by Dr. Camillo Ricordi was granted immediate FDA authorization for a 24-patient clinical trial to test the safety and exploratory efficacy of...
![Mesoblast’s Stem Cell Therapy Shows 83% Survival in Ventilator-Dependent COVID-19 Patients]()
by admin | Mar 31, 2020 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
As the situation with COVID-19 evolves, Gift of Life wanted to shine a light on the doctors, nurses and health care workers who are tirelessly serving on the front lines. To support their important work, Gift of Life donated 10,000 urgently-needed swabs to Baptist...
